1,636
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Race, inequality and the medicalization of drug addiction: an analysis of documentary films

, &
Pages 319-332 | Received 18 Nov 2013, Accepted 22 Apr 2014, Published online: 06 Jun 2014

References

  • Acker, C. J. (2002). Creating the American Junkie: Addiction Research in the Classic Era of Narcotics Control. Baltimore, MD: Johns Hopkins University Press
  • Agar, M. (1977). Going through the changes: Methadone in New York City. Human Organization, 36, 291–295
  • Anderson, T. L., Lane, D., & Swan, H. (2010). Institutional fads and the medicalization of drug addiction. Sociology Compass, 4, 476–494
  • Azoulay, K. G. (2006). Reflections on ‘race’ and the biologization of difference. Patterns of Prejudice, 40, 353–379
  • Beckett, K., Nyrop, K., Pfingst, L., & Bowell, M. (2005). Drug use, drug possession arrests, and the question of race. Social Problems, 52, 419–441
  • Berridge, V. (2014). Demons: Our Changing Attitudes to Alcohol, Tobacco and Drugs. New York: Oxford University Press
  • Bonnie, R. J., & Whitebread, C. H. (1999). The Marijuana Conviction: A History of Marijuana Prohibition in the United States. New York: The Lindesmith Center
  • Bourgois, P. (2000). Disciplining addictions: The bio-politics of methadone and heroin in the United States. Culture, Medicine and Psychiatry, 24, 165–195
  • Bourgois, P. (2003). Crack and the political economy of social suffering. Addiction Research & Theory, 11, 31–37
  • Brecher, E. M. (1972). The Consumers Union Report on Licit and Illicit Drugs. Boston: Little Brown
  • Bridges, G. S., & Steen, S. (1998). Racial disparities in official assessments of juvenile offenders: Attributional stereotypes as mediating mechanisms. American Sociological Review, 63, 554–570
  • Campbell, N. D. (2000). Using Women: Gender, Drug Policy and Social Justice. New York: Routledge
  • Centers for Disease Control and Prevention (CDC). (2011). Policy Impact: Prescription Painkiller Overdoses. Atlanta: CDC
  • Clarke, A. E., Shim, J. K., Mamo, L., Fosket, J. R., & Fishman, J. R. (2003). Biomedicalization: Technoscientific transformations of health, illness, and U.S. biomedicine. American Sociological Review, 68, 161–194
  • Cohen, M. M. (2006). Jim Crow’s drug war: Race, coca cola, and the southern origins of drug prohibition. Southern Cultures, 12, 55–79
  • Conrad, P. (1992). Medicalization and social control. Annual Review of Sociology, 18, 209–232
  • Courtwright, D. (2001). Forces of Habit: Drugs and the Making of the Modern World. Cambridge: Harvard University Press
  • Courtwright, D. (2010). The NIDA brain disease paradigm: History, resistance and spinoffs. BioSocieties, 5, 137–147
  • Daniels, J. (2012). Intervention: Reality TV, whiteness, and narratives of addiction. Advances in Medical Sociology, 14, 103–125
  • Davis, W. (1996). One river: Explorations and Discoveries in the Amazon Rainforest. New York: Simon and Shuster
  • DuPont R. (2009). Reflections on the early history of the National Institute on Drug Abuse (NIDA): Implications for today. Journal of Drug Issues, 39, 5–14
  • Duster, T. (2003). Backdoor to Eugenics (2nd ed.). New York: Routledge
  • Duster, T. (2006). Comparative perspectives and competing explanations: Taking on the newly configured reductionist challenge to sociology. American Sociological Review, 71, 1–15
  • Entman, R. M., & Rojecki, A. (2000). The Black Image in the White Mind: Media and Race in America. Chicago: University of Chicago Press
  • Epstein, S. (2004). Bodily differences and collective identities: The politics of gender and race in biomedical research in the United States. Body & Society, 10, 183–203
  • Fullwiley, D. (2008). The molecularization of race and institutions of difference: Pharmacy and public science after the genome. In B. A. Koenig, S. S. Lee, & S. Richardson (Eds.), Revisiting Race in a Genomic Age (pp. 149–171). New Brunswick, NJ: Rutgers University Press
  • Golub, A., Johnson, B. D., Dunlap, E., & Sifaneck, S. (2004). Projecting and monitoring the life course of the marijuana/blunts generation. Journal of Drug Issues, 34, 361–388
  • Hall, S. (1997). Representations: Cultural Representations and Signifying Practices. Thousand Oaks, CA: Sage
  • Hickman, T. A. (2004). The double meaning of addiction: Habitual narcotic use and the logic of professionalizing medical authority in the United States, 1900–1920. In S W. Tracy, & C. J. Acker (Eds.), Altering American Consciousness: The History of Alcohol and Drug Use in the United States, 1800–2000 (pp. 182–199). Amherst: University of Massachusetts Press
  • Hughey, M. W. (2012). Racializing redemption, reproducing racism: The odyssey of magical Negroes and White saviors. Sociology Compass, 6, 751–767
  • Hunt, D. E. (2006). Methamphetamine abuse: Challenges for law enforcement and communities. NIJ Journal, 254, 24–28
  • King, R. S., & Pasquarella, J. (2009). Drug Courts: A Review of the Evidence. Washington, DC: U.S. Sentencing Project
  • Kohn, M. (1992). Dope girls: The Birth of the British Drug Underground. London: Granta
  • Leshner, A. (1997). Addiction is a brain disease, and it matters. Science, 278, 45–47
  • Lynch, J., Bevan, J., Achter, P., Harris, T., & Condit, C. M. (2008). A preliminary study of how multiple exposures to messages about genetics impact on lay attitudes towards racial and genetic discrimination. New Genetics and Society, 27, 43–56
  • Manderson, D. (1995). Metamorphoses: Clashing symbols in the social construction of drugs. Journal of Drug Issues, 25, 799–816
  • Mauer, M. (2006). Race to Incarcerate. New York: New Press
  • Massing, M. (1998). The fix. New York: Simon and Shuster
  • Musto, D. (1999). The American Disease: Origins of Narcotic Control (3rd ed.). New York: Oxford University Press
  • Musto, D. (2002). Drugs in America: A Documentary History. New York: New York University Press
  • National Institute on Drug Abuse (NIDA). (2009). Drug, brains, and behavior: The science of addiction. Available at: http://www.drugabuse.gov/scienceofaddiction/
  • Office of National Drug Control Policy (ONDCP). (2011). National drug control strategy, 2010. Available at: http://www.whitehouse.gov/ondcp/national-drug-control-strategy-introduction
  • Phelan, J. C. (2005). Geneticization of deviant behavior and consequences for stigma: The case of mental illness. Journal of Health and Social Behavior, 46, 307–322
  • Provine, D. (2007). Unequal Under the Law: Race and the War on Drugs. Chicago: University of Chicago Press
  • Reinarman, C., & Levine, H. (1997). Crack in America: Demon Drugs and Social Justice. Berkeley: University of California Press
  • Rose, N. (2007). The Politics of Life Itself: Biomedicine, Power, and Subjectivity in the Twenty-first Century. Princeton: Princeton University Press
  • Sloman, D. (1979). Reefer Madness. New York: St. Martin’s Press
  • Sofuoglu, M., Poling, J., Gonzalez, G., Gonsai, K., Oliveto, A., & Kosten, T. R. (2007). Progesterone effects on cocaine use in male cocaine users maintained on methadone: A randomized, double-blind, pilot study. Experimental and Clinical Psychopharmacology, 15, 453–460
  • Spillane, J. F. (2000). Cocaine: From Medical Marvel to Modern Menace in the United States, 1884–1920. Baltimore: Johns Hopkins University Press
  • Thompson, M. (2010). Race, gender and the social construction of mental illness in the criminal justice system. Sociological Perspectives, 53, 99–125
  • Turner, P. A. (1994). Ceramic Uncles and Celluloid Mammies: Black Images and their Influence on Culture. Charlottesville, VA: University of Virginia Press
  • Volkow, N. (2009). Fiscal Year 2010 Budget Request before the Senate Subcommittee on Labor-HHS-education Appropriations. Testimony to U.S. Congress, May 21
  • Wacquant, L. (2002). The curious eclipse of prison ethnography in the age of mass incarceration. Ethnography, 3, 371–397
  • Waldorf, D., Reinarman, C., & Murphy, S. (1991). Cocaine Changes: The Experience of Using and Quitting. Philadelphia: Temple University Press
  • Williams, E. H. (1914, February 8). Negro cocaine “fiends” are a new southern menace. The New York Times, SM12

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.